ImpediMed Limited (ASX:IPD)
Australia · Delayed Price · Currency is AUD 0.0050
0.00 (0.00%)
Aug 28, 2026, 4:10 PM AEST
ImpediMed Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 14.61 | 12.72 | 10.32 | 11.34 | 10.5 |
Other Revenue | - | - | - | - | 0.07 |
| 14.61 | 12.72 | 10.32 | 11.34 | 10.57 | |
Revenue Growth | 14.85% | 23.31% | -9.04% | 7.36% | 25.65% |
Cost of Revenue | 1.84 | 1.75 | 1.31 | 1.55 | 1.71 |
Gross Profit | 12.77 | 10.98 | 9.01 | 9.8 | 8.86 |
Selling, General & Admin | 25.57 | 26.48 | 26.19 | 25.29 | 23.67 |
Research & Development | 0.2 | 0.15 | 0.22 | 0.6 | 0.68 |
Other Operating Expenses | 3.17 | 2.79 | 3.41 | 4.31 | 3.2 |
Operating Expenses | 34.01 | 33.98 | 32.08 | 32.66 | 30.32 |
Operating Income | -21.24 | -23.01 | -23.07 | -22.87 | -21.47 |
Interest Expense | -4.37 | -1.16 | -0.09 | -0.03 | -0.03 |
Interest & Investment Income | - | 0.96 | 1.56 | 0.8 | 0.05 |
Other Non Operating Income (Expenses) | 0.73 | - | - | 1.61 | 1.62 |
EBT Excluding Unusual Items | -24.88 | -23.21 | -21.6 | -20.49 | -19.83 |
Other Unusual Items | - | - | 1.85 | - | - |
Pretax Income | -24.88 | -23.21 | -19.76 | -20.49 | -19.83 |
Income Tax Expense | 0.03 | 0.03 | 0.03 | 0.03 | 0.05 |
Earnings From Continuing Operations | -24.91 | -23.24 | -19.79 | -20.52 | -19.87 |
Net Income | -24.91 | -23.24 | -19.79 | -20.52 | -19.87 |
Net Income to Common | -24.91 | -23.24 | -19.79 | -20.52 | -19.87 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 2,491 | 2,019 | 2,022 | 1,800 | 1,679 |
Shares Outstanding (Diluted) | 2,491 | 2,019 | 2,022 | 1,800 | 1,679 |
Shares Change | 23.35% | -0.13% | 12.30% | 7.23% | 39.64% |
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -17.92 | -14.71 | -17.87 | -18.44 | -15.72 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Gross Margin | 87.39% | 86.25% | 87.27% | 86.37% | 83.83% |
Operating Margin | -145.36% | -180.82% | -223.57% | -201.56% | -203.16% |
Profit Margin | -170.44% | -182.62% | -191.78% | -180.90% | -188.09% |
Free Cash Flow Margin | -122.64% | -115.57% | -173.18% | -162.56% | -148.82% |
EBITDA | -17.02 | -22.78 | -22.8 | -22.61 | -20.23 |
EBITDA Margin | -116.48% | -178.99% | -220.97% | -199.32% | -191.46% |
D&A For EBITDA | 4.22 | 0.23 | 0.27 | 0.25 | 1.24 |
EBIT | -21.24 | -23.01 | -23.07 | -22.87 | -21.47 |
EBIT Margin | -145.36% | -180.82% | -223.57% | -201.56% | -203.16% |
Revenue as Reported | - | - | - | - | 10.56 |
Advertising Expenses | - | 0.8 | 0.52 | 0.46 | 0.67 |